InterCare DX, Inc.
InterCare DX, Inc. ICCO Peers
See (ICCO) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ICCO | $0.00 | +0.00% | 71.7K | -0.40 | -$0.01 | N/A |
| PMCUF | $185.00 | +2.96% | 19.3B | 303.28 | $0.61 | +0.16% |
| MTHRY | $6.68 | -1.40% | 9B | 31.71 | $0.21 | N/A |
| MTHRF | $13.65 | +0.00% | 8.8B | 31.66 | $0.41 | +1.08% |
| PANHF | $0.91 | +0.00% | 1.8B | 84.90 | $0.01 | +146.83% |
| CMPVF | $23.75 | -0.44% | 1.2B | 40.95 | $0.58 | +4.21% |
| PIAHY | $2.29 | +0.00% | 1.2B | 112.00 | $0.02 | +110.97% |
| CMPUY | $23.00 | -7.26% | 1.2B | 38.98 | $0.59 | N/A |
| RSLBF | $32.05 | +0.00% | 1.1B | 47.84 | $0.67 | +0.98% |
| CRWRF | $29.25 | +0.00% | 956.7M | 65.05 | $0.42 | +1.38% |
Stock Comparison
ICCO vs PMCUF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, PMCUF has a market cap of 19.3B. Regarding current trading prices, ICCO is priced at $0.00, while PMCUF trades at $185.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas PMCUF's P/E ratio is 303.28. In terms of profitability, ICCO's ROE is +0.17%, compared to PMCUF's ROE of +0.48%. Regarding short-term risk, ICCO and PMCUF have similar daily volatility (0.00).
ICCO vs MTHRY Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, MTHRY has a market cap of 9B. Regarding current trading prices, ICCO is priced at $0.00, while MTHRY trades at $6.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas MTHRY's P/E ratio is 31.71. In terms of profitability, ICCO's ROE is +0.17%, compared to MTHRY's ROE of +0.09%. Regarding short-term risk, ICCO and MTHRY have similar daily volatility (0.00).
ICCO vs MTHRF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, MTHRF has a market cap of 8.8B. Regarding current trading prices, ICCO is priced at $0.00, while MTHRF trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas MTHRF's P/E ratio is 31.66. In terms of profitability, ICCO's ROE is +0.17%, compared to MTHRF's ROE of +0.09%. Regarding short-term risk, ICCO and MTHRF have similar daily volatility (0.00).
ICCO vs PANHF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, PANHF has a market cap of 1.8B. Regarding current trading prices, ICCO is priced at $0.00, while PANHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas PANHF's P/E ratio is 84.90. In terms of profitability, ICCO's ROE is +0.17%, compared to PANHF's ROE of -0.00%. Regarding short-term risk, ICCO and PANHF have similar daily volatility (0.00).
ICCO vs CMPVF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CMPVF has a market cap of 1.2B. Regarding current trading prices, ICCO is priced at $0.00, while CMPVF trades at $23.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CMPVF's P/E ratio is 40.95. In terms of profitability, ICCO's ROE is +0.17%, compared to CMPVF's ROE of +0.04%. Regarding short-term risk, ICCO and CMPVF have similar daily volatility (0.00).
ICCO vs PIAHY Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, PIAHY has a market cap of 1.2B. Regarding current trading prices, ICCO is priced at $0.00, while PIAHY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas PIAHY's P/E ratio is 112.00. In terms of profitability, ICCO's ROE is +0.17%, compared to PIAHY's ROE of -0.00%. Regarding short-term risk, ICCO and PIAHY have similar daily volatility (0.00).
ICCO vs CMPUY Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CMPUY has a market cap of 1.2B. Regarding current trading prices, ICCO is priced at $0.00, while CMPUY trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CMPUY's P/E ratio is 38.98. In terms of profitability, ICCO's ROE is +0.17%, compared to CMPUY's ROE of +0.04%. Regarding short-term risk, ICCO and CMPUY have similar daily volatility (0.00).
ICCO vs RSLBF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, RSLBF has a market cap of 1.1B. Regarding current trading prices, ICCO is priced at $0.00, while RSLBF trades at $32.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas RSLBF's P/E ratio is 47.84. In terms of profitability, ICCO's ROE is +0.17%, compared to RSLBF's ROE of +0.26%. Regarding short-term risk, ICCO and RSLBF have similar daily volatility (0.00).
ICCO vs CRWRF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CRWRF has a market cap of 956.7M. Regarding current trading prices, ICCO is priced at $0.00, while CRWRF trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CRWRF's P/E ratio is 65.05. In terms of profitability, ICCO's ROE is +0.17%, compared to CRWRF's ROE of +0.04%. Regarding short-term risk, ICCO and CRWRF have similar daily volatility (0.00).
ICCO vs SMSZF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, SMSZF has a market cap of 876M. Regarding current trading prices, ICCO is priced at $0.00, while SMSZF trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas SMSZF's P/E ratio is 21.04. In terms of profitability, ICCO's ROE is +0.17%, compared to SMSZF's ROE of +0.20%. Regarding short-term risk, ICCO and SMSZF have similar daily volatility (0.00).
ICCO vs SUSRF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, SUSRF has a market cap of 790.9M. Regarding current trading prices, ICCO is priced at $0.00, while SUSRF trades at $15.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas SUSRF's P/E ratio is 53.45. In terms of profitability, ICCO's ROE is +0.17%, compared to SUSRF's ROE of +0.03%. Regarding short-term risk, ICCO and SUSRF have similar daily volatility (0.00).
ICCO vs VHIBF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, VHIBF has a market cap of 429.2M. Regarding current trading prices, ICCO is priced at $0.00, while VHIBF trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas VHIBF's P/E ratio is 265.00. In terms of profitability, ICCO's ROE is +0.17%, compared to VHIBF's ROE of +0.02%. Regarding short-term risk, ICCO and VHIBF have similar daily volatility (0.00).
ICCO vs KSIOF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, KSIOF has a market cap of 424.8M. Regarding current trading prices, ICCO is priced at $0.00, while KSIOF trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas KSIOF's P/E ratio is -225.00. In terms of profitability, ICCO's ROE is +0.17%, compared to KSIOF's ROE of -0.05%. Regarding short-term risk, ICCO is less volatile compared to KSIOF. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs ONVVF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, ONVVF has a market cap of 332.8M. Regarding current trading prices, ICCO is priced at $0.00, while ONVVF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas ONVVF's P/E ratio is -20.00. In terms of profitability, ICCO's ROE is +0.17%, compared to ONVVF's ROE of -0.97%. Regarding short-term risk, ICCO and ONVVF have similar daily volatility (0.00).
ICCO vs ACMLF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, ACMLF has a market cap of 317.5M. Regarding current trading prices, ICCO is priced at $0.00, while ACMLF trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas ACMLF's P/E ratio is 73.67. In terms of profitability, ICCO's ROE is +0.17%, compared to ACMLF's ROE of +0.21%. Regarding short-term risk, ICCO and ACMLF have similar daily volatility (0.00).
ICCO vs SMDCF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, SMDCF has a market cap of 280.9M. Regarding current trading prices, ICCO is priced at $0.00, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, ICCO's ROE is +0.17%, compared to SMDCF's ROE of N/A. Regarding short-term risk, ICCO and SMDCF have similar daily volatility (0.00).
ICCO vs DLHTF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, DLHTF has a market cap of 254.8M. Regarding current trading prices, ICCO is priced at $0.00, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, ICCO's ROE is +0.17%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, ICCO and DLHTF have similar daily volatility (0.00).
ICCO vs COGZF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, COGZF has a market cap of 194.1M. Regarding current trading prices, ICCO is priced at $0.00, while COGZF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas COGZF's P/E ratio is 28.75. In terms of profitability, ICCO's ROE is +0.17%, compared to COGZF's ROE of +0.17%. Regarding short-term risk, ICCO is less volatile compared to COGZF. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs VPAHF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, VPAHF has a market cap of 188.2M. Regarding current trading prices, ICCO is priced at $0.00, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, ICCO's ROE is +0.17%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, ICCO and VPAHF have similar daily volatility (0.00).
ICCO vs CSAMF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CSAMF has a market cap of 98.8M. Regarding current trading prices, ICCO is priced at $0.00, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, ICCO's ROE is +0.17%, compared to CSAMF's ROE of -1.58%. Regarding short-term risk, ICCO and CSAMF have similar daily volatility (0.00).
ICCO vs MDPEF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, MDPEF has a market cap of 85.8M. Regarding current trading prices, ICCO is priced at $0.00, while MDPEF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas MDPEF's P/E ratio is 8.40. In terms of profitability, ICCO's ROE is +0.17%, compared to MDPEF's ROE of N/A. Regarding short-term risk, ICCO and MDPEF have similar daily volatility (0.00).
ICCO vs HITC Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, HITC has a market cap of 52.8M. Regarding current trading prices, ICCO is priced at $0.00, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas HITC's P/E ratio is -14.75. In terms of profitability, ICCO's ROE is +0.17%, compared to HITC's ROE of -1.29%. Regarding short-term risk, ICCO is less volatile compared to HITC. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs RTNXF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, RTNXF has a market cap of 22.5M. Regarding current trading prices, ICCO is priced at $0.00, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, ICCO's ROE is +0.17%, compared to RTNXF's ROE of +2.93%. Regarding short-term risk, ICCO is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs TREIF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, TREIF has a market cap of 22.4M. Regarding current trading prices, ICCO is priced at $0.00, while TREIF trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas TREIF's P/E ratio is -2.12. In terms of profitability, ICCO's ROE is +0.17%, compared to TREIF's ROE of -11.21%. Regarding short-term risk, ICCO and TREIF have similar daily volatility (0.00).
ICCO vs VASO Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, VASO has a market cap of 22.1M. Regarding current trading prices, ICCO is priced at $0.00, while VASO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas VASO's P/E ratio is 12.60. In terms of profitability, ICCO's ROE is +0.17%, compared to VASO's ROE of +0.04%. Regarding short-term risk, ICCO is less volatile compared to VASO. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs HDSLF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, HDSLF has a market cap of 21.1M. Regarding current trading prices, ICCO is priced at $0.00, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, ICCO's ROE is +0.17%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, ICCO is less volatile compared to HDSLF. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs THKKF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, THKKF has a market cap of 17.8M. Regarding current trading prices, ICCO is priced at $0.00, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas THKKF's P/E ratio is -1.51. In terms of profitability, ICCO's ROE is +0.17%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, ICCO and THKKF have similar daily volatility (0.00).
ICCO vs MNNDF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, MNNDF has a market cap of 14.3M. Regarding current trading prices, ICCO is priced at $0.00, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, ICCO's ROE is +0.17%, compared to MNNDF's ROE of N/A. Regarding short-term risk, ICCO is less volatile compared to MNNDF. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs DGNOF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, DGNOF has a market cap of 13.8M. Regarding current trading prices, ICCO is priced at $0.00, while DGNOF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas DGNOF's P/E ratio is -3.37. In terms of profitability, ICCO's ROE is +0.17%, compared to DGNOF's ROE of +2.18%. Regarding short-term risk, ICCO and DGNOF have similar daily volatility (0.00).
ICCO vs PBSV Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, PBSV has a market cap of 11.7M. Regarding current trading prices, ICCO is priced at $0.00, while PBSV trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas PBSV's P/E ratio is -51.00. In terms of profitability, ICCO's ROE is +0.17%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, ICCO and PBSV have similar daily volatility (0.00).
ICCO vs UDOCF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, UDOCF has a market cap of 10.9M. Regarding current trading prices, ICCO is priced at $0.00, while UDOCF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas UDOCF's P/E ratio is -2.37. In terms of profitability, ICCO's ROE is +0.17%, compared to UDOCF's ROE of +6.57%. Regarding short-term risk, ICCO is less volatile compared to UDOCF. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs CRVW Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CRVW has a market cap of 10.2M. Regarding current trading prices, ICCO is priced at $0.00, while CRVW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CRVW's P/E ratio is -1.75. In terms of profitability, ICCO's ROE is +0.17%, compared to CRVW's ROE of +0.16%. Regarding short-term risk, ICCO is less volatile compared to CRVW. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs CDXFF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CDXFF has a market cap of 9.7M. Regarding current trading prices, ICCO is priced at $0.00, while CDXFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CDXFF's P/E ratio is -1.35. In terms of profitability, ICCO's ROE is +0.17%, compared to CDXFF's ROE of +0.44%. Regarding short-term risk, ICCO and CDXFF have similar daily volatility (0.00).
ICCO vs HSCHF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, HSCHF has a market cap of 9.5M. Regarding current trading prices, ICCO is priced at $0.00, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas HSCHF's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to HSCHF's ROE of +0.00%. Regarding short-term risk, ICCO and HSCHF have similar daily volatility (0.00).
ICCO vs VYND Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, VYND has a market cap of 9.2M. Regarding current trading prices, ICCO is priced at $0.00, while VYND trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas VYND's P/E ratio is -49.99. In terms of profitability, ICCO's ROE is +0.17%, compared to VYND's ROE of +0.48%. Regarding short-term risk, ICCO and VYND have similar daily volatility (0.00).
ICCO vs HBCNF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, HBCNF has a market cap of 8.4M. Regarding current trading prices, ICCO is priced at $0.00, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, ICCO's ROE is +0.17%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, ICCO is less volatile compared to HBCNF. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs SPLTF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, SPLTF has a market cap of 8M. Regarding current trading prices, ICCO is priced at $0.00, while SPLTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, ICCO's ROE is +0.17%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, ICCO and SPLTF have similar daily volatility (0.00).
ICCO vs AIMLF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, AIMLF has a market cap of 7.8M. Regarding current trading prices, ICCO is priced at $0.00, while AIMLF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas AIMLF's P/E ratio is -1.13. In terms of profitability, ICCO's ROE is +0.17%, compared to AIMLF's ROE of -11.81%. Regarding short-term risk, ICCO is less volatile compared to AIMLF. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs EMOR Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, EMOR has a market cap of 7M. Regarding current trading prices, ICCO is priced at $0.00, while EMOR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas EMOR's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to EMOR's ROE of +0.28%. Regarding short-term risk, ICCO and EMOR have similar daily volatility (0.00).
ICCO vs CRBKF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CRBKF has a market cap of 6.8M. Regarding current trading prices, ICCO is priced at $0.00, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, ICCO's ROE is +0.17%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, ICCO and CRBKF have similar daily volatility (0.00).
ICCO vs DOCRF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, DOCRF has a market cap of 6.2M. Regarding current trading prices, ICCO is priced at $0.00, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, ICCO's ROE is +0.17%, compared to DOCRF's ROE of -2.21%. Regarding short-term risk, ICCO and DOCRF have similar daily volatility (0.00).
ICCO vs CNONF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CNONF has a market cap of 5M. Regarding current trading prices, ICCO is priced at $0.00, while CNONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CNONF's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, ICCO and CNONF have similar daily volatility (0.00).
ICCO vs RYAHF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, RYAHF has a market cap of 5M. Regarding current trading prices, ICCO is priced at $0.00, while RYAHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, ICCO's ROE is +0.17%, compared to RYAHF's ROE of +0.00%. Regarding short-term risk, ICCO and RYAHF have similar daily volatility (0.00).
ICCO vs CMPD Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CMPD has a market cap of 4.4M. Regarding current trading prices, ICCO is priced at $0.00, while CMPD trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CMPD's P/E ratio is -15.30. In terms of profitability, ICCO's ROE is +0.17%, compared to CMPD's ROE of +0.07%. Regarding short-term risk, ICCO and CMPD have similar daily volatility (0.00).
ICCO vs CBDS Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CBDS has a market cap of 4.3M. Regarding current trading prices, ICCO is priced at $0.00, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CBDS's P/E ratio is -1.48. In terms of profitability, ICCO's ROE is +0.17%, compared to CBDS's ROE of +1.55%. Regarding short-term risk, ICCO is less volatile compared to CBDS. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs IQAIF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, IQAIF has a market cap of 4.2M. Regarding current trading prices, ICCO is priced at $0.00, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas IQAIF's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to IQAIF's ROE of -1.62%. Regarding short-term risk, ICCO and IQAIF have similar daily volatility (0.00).
ICCO vs CTVEF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CTVEF has a market cap of 3.9M. Regarding current trading prices, ICCO is priced at $0.00, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CTVEF's P/E ratio is -0.16. In terms of profitability, ICCO's ROE is +0.17%, compared to CTVEF's ROE of +0.08%. Regarding short-term risk, ICCO and CTVEF have similar daily volatility (0.00).
ICCO vs LVCE Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, LVCE has a market cap of 3.7M. Regarding current trading prices, ICCO is priced at $0.00, while LVCE trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas LVCE's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to LVCE's ROE of N/A. Regarding short-term risk, ICCO and LVCE have similar daily volatility (0.00).
ICCO vs EKGGF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, EKGGF has a market cap of 3.3M. Regarding current trading prices, ICCO is priced at $0.00, while EKGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas EKGGF's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to EKGGF's ROE of +0.54%. Regarding short-term risk, ICCO and EKGGF have similar daily volatility (0.00).
ICCO vs MITI Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, MITI has a market cap of 3.2M. Regarding current trading prices, ICCO is priced at $0.00, while MITI trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas MITI's P/E ratio is -9.33. In terms of profitability, ICCO's ROE is +0.17%, compared to MITI's ROE of -0.05%. Regarding short-term risk, ICCO and MITI have similar daily volatility (0.00).
ICCO vs EBYH Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, EBYH has a market cap of 2.1M. Regarding current trading prices, ICCO is priced at $0.00, while EBYH trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas EBYH's P/E ratio is -6.00. In terms of profitability, ICCO's ROE is +0.17%, compared to EBYH's ROE of -0.03%. Regarding short-term risk, ICCO and EBYH have similar daily volatility (0.00).
ICCO vs BNVIF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, BNVIF has a market cap of 1.7M. Regarding current trading prices, ICCO is priced at $0.00, while BNVIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas BNVIF's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, ICCO and BNVIF have similar daily volatility (0.00).
ICCO vs TSTTF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, TSTTF has a market cap of 922.5K. Regarding current trading prices, ICCO is priced at $0.00, while TSTTF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas TSTTF's P/E ratio is -3.33. In terms of profitability, ICCO's ROE is +0.17%, compared to TSTTF's ROE of +0.33%. Regarding short-term risk, ICCO and TSTTF have similar daily volatility (0.00).
ICCO vs EVAHF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, EVAHF has a market cap of 871.3K. Regarding current trading prices, ICCO is priced at $0.00, while EVAHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas EVAHF's P/E ratio is -7.50. In terms of profitability, ICCO's ROE is +0.17%, compared to EVAHF's ROE of +0.29%. Regarding short-term risk, ICCO and EVAHF have similar daily volatility (0.00).
ICCO vs MDBIF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, MDBIF has a market cap of 867.8K. Regarding current trading prices, ICCO is priced at $0.00, while MDBIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas MDBIF's P/E ratio is -0.14. In terms of profitability, ICCO's ROE is +0.17%, compared to MDBIF's ROE of -0.14%. Regarding short-term risk, ICCO and MDBIF have similar daily volatility (0.00).
ICCO vs MDXL Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, MDXL has a market cap of 801K. Regarding current trading prices, ICCO is priced at $0.00, while MDXL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas MDXL's P/E ratio is -0.10. In terms of profitability, ICCO's ROE is +0.17%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, ICCO and MDXL have similar daily volatility (0.00).
ICCO vs DTRK Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, DTRK has a market cap of 680.8K. Regarding current trading prices, ICCO is priced at $0.00, while DTRK trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas DTRK's P/E ratio is -4.84. In terms of profitability, ICCO's ROE is +0.17%, compared to DTRK's ROE of -9.79%. Regarding short-term risk, ICCO and DTRK have similar daily volatility (0.00).
ICCO vs NEWUF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, NEWUF has a market cap of 634.6K. Regarding current trading prices, ICCO is priced at $0.00, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas NEWUF's P/E ratio is -0.03. In terms of profitability, ICCO's ROE is +0.17%, compared to NEWUF's ROE of +0.67%. Regarding short-term risk, ICCO and NEWUF have similar daily volatility (0.00).
ICCO vs CSOC Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CSOC has a market cap of 553.4K. Regarding current trading prices, ICCO is priced at $0.00, while CSOC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CSOC's P/E ratio is 0.20. In terms of profitability, ICCO's ROE is +0.17%, compared to CSOC's ROE of -2.38%. Regarding short-term risk, ICCO is less volatile compared to CSOC. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs MDNWF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, MDNWF has a market cap of 517.3K. Regarding current trading prices, ICCO is priced at $0.00, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, ICCO's ROE is +0.17%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, ICCO and MDNWF have similar daily volatility (0.00).
ICCO vs MDRM Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, MDRM has a market cap of 497.4K. Regarding current trading prices, ICCO is priced at $0.00, while MDRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas MDRM's P/E ratio is -0.39. In terms of profitability, ICCO's ROE is +0.17%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, ICCO and MDRM have similar daily volatility (0.00).
ICCO vs PPJE Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, PPJE has a market cap of 460.2K. Regarding current trading prices, ICCO is priced at $0.00, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas PPJE's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to PPJE's ROE of +0.00%. Regarding short-term risk, ICCO is less volatile compared to PPJE. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs NDATF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, NDATF has a market cap of 450.5K. Regarding current trading prices, ICCO is priced at $0.00, while NDATF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas NDATF's P/E ratio is -0.55. In terms of profitability, ICCO's ROE is +0.17%, compared to NDATF's ROE of -0.62%. Regarding short-term risk, ICCO and NDATF have similar daily volatility (0.00).
ICCO vs ACHKF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, ACHKF has a market cap of 377.4K. Regarding current trading prices, ICCO is priced at $0.00, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas ACHKF's P/E ratio is -0.05. In terms of profitability, ICCO's ROE is +0.17%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, ICCO and ACHKF have similar daily volatility (0.00).
ICCO vs NHIQ Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, NHIQ has a market cap of 302.2K. Regarding current trading prices, ICCO is priced at $0.00, while NHIQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas NHIQ's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, ICCO and NHIQ have similar daily volatility (0.00).
ICCO vs LFCOF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, LFCOF has a market cap of 282K. Regarding current trading prices, ICCO is priced at $0.00, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, ICCO's ROE is +0.17%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, ICCO and LFCOF have similar daily volatility (0.00).
ICCO vs ALDNF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, ALDNF has a market cap of 160.4K. Regarding current trading prices, ICCO is priced at $0.00, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas ALDNF's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to ALDNF's ROE of +0.00%. Regarding short-term risk, ICCO and ALDNF have similar daily volatility (0.00).
ICCO vs USPS Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, USPS has a market cap of 158.5K. Regarding current trading prices, ICCO is priced at $0.00, while USPS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas USPS's P/E ratio is -1.00. In terms of profitability, ICCO's ROE is +0.17%, compared to USPS's ROE of -0.63%. Regarding short-term risk, ICCO and USPS have similar daily volatility (0.00).
ICCO vs EMYSF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, EMYSF has a market cap of 151.7K. Regarding current trading prices, ICCO is priced at $0.00, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas EMYSF's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to EMYSF's ROE of +0.00%. Regarding short-term risk, ICCO and EMYSF have similar daily volatility (0.00).
ICCO vs CMHSF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CMHSF has a market cap of 111.6K. Regarding current trading prices, ICCO is priced at $0.00, while CMHSF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CMHSF's P/E ratio is 0.05. In terms of profitability, ICCO's ROE is +0.17%, compared to CMHSF's ROE of +0.10%. Regarding short-term risk, ICCO and CMHSF have similar daily volatility (0.00).
ICCO vs DSOL Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, DSOL has a market cap of 88.9K. Regarding current trading prices, ICCO is priced at $0.00, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas DSOL's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to DSOL's ROE of +0.05%. Regarding short-term risk, ICCO and DSOL have similar daily volatility (0.00).
ICCO vs PASO Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, PASO has a market cap of 74.1K. Regarding current trading prices, ICCO is priced at $0.00, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas PASO's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to PASO's ROE of +6.20%. Regarding short-term risk, ICCO and PASO have similar daily volatility (0.00).
ICCO vs REFG Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, REFG has a market cap of 60.8K. Regarding current trading prices, ICCO is priced at $0.00, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas REFG's P/E ratio is -0.01. In terms of profitability, ICCO's ROE is +0.17%, compared to REFG's ROE of +0.01%. Regarding short-term risk, ICCO and REFG have similar daily volatility (0.00).
ICCO vs HDVY Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, HDVY has a market cap of 41.2K. Regarding current trading prices, ICCO is priced at $0.00, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas HDVY's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to HDVY's ROE of +0.00%. Regarding short-term risk, ICCO and HDVY have similar daily volatility (0.00).
ICCO vs RVRC Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, RVRC has a market cap of 40.4K. Regarding current trading prices, ICCO is priced at $0.00, while RVRC trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas RVRC's P/E ratio is -0.11. In terms of profitability, ICCO's ROE is +0.17%, compared to RVRC's ROE of -0.29%. Regarding short-term risk, ICCO and RVRC have similar daily volatility (0.00).
ICCO vs IGRW Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, IGRW has a market cap of 39.8K. Regarding current trading prices, ICCO is priced at $0.00, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas IGRW's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to IGRW's ROE of +7.88%. Regarding short-term risk, ICCO and IGRW have similar daily volatility (0.00).
ICCO vs WMGR Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, WMGR has a market cap of 36.3K. Regarding current trading prices, ICCO is priced at $0.00, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas WMGR's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to WMGR's ROE of +0.00%. Regarding short-term risk, ICCO and WMGR have similar daily volatility (0.00).
ICCO vs SSYNF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, SSYNF has a market cap of 33.3K. Regarding current trading prices, ICCO is priced at $0.00, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, ICCO's ROE is +0.17%, compared to SSYNF's ROE of N/A. Regarding short-term risk, ICCO and SSYNF have similar daily volatility (0.00).
ICCO vs SOFE Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, SOFE has a market cap of 31K. Regarding current trading prices, ICCO is priced at $0.00, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas SOFE's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, ICCO and SOFE have similar daily volatility (0.00).
ICCO vs TTBLF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, TTBLF has a market cap of 26.7K. Regarding current trading prices, ICCO is priced at $0.00, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, ICCO's ROE is +0.17%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, ICCO is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.
ICCO vs ORHB Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, ORHB has a market cap of 25.6K. Regarding current trading prices, ICCO is priced at $0.00, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas ORHB's P/E ratio is -0.01. In terms of profitability, ICCO's ROE is +0.17%, compared to ORHB's ROE of +0.33%. Regarding short-term risk, ICCO and ORHB have similar daily volatility (0.00).
ICCO vs EWLL Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, EWLL has a market cap of 18.5K. Regarding current trading prices, ICCO is priced at $0.00, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas EWLL's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to EWLL's ROE of +0.00%. Regarding short-term risk, ICCO and EWLL have similar daily volatility (0.00).
ICCO vs NHEL Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, NHEL has a market cap of 16.2K. Regarding current trading prices, ICCO is priced at $0.00, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas NHEL's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to NHEL's ROE of +0.00%. Regarding short-term risk, ICCO and NHEL have similar daily volatility (0.00).
ICCO vs RQHTF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, RQHTF has a market cap of 15.2K. Regarding current trading prices, ICCO is priced at $0.00, while RQHTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas RQHTF's P/E ratio is -0.07. In terms of profitability, ICCO's ROE is +0.17%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, ICCO and RQHTF have similar daily volatility (0.00).
ICCO vs FDBH Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, FDBH has a market cap of 15K. Regarding current trading prices, ICCO is priced at $0.00, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas FDBH's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, ICCO and FDBH have similar daily volatility (0.00).
ICCO vs HLTT Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, HLTT has a market cap of 10.7K. Regarding current trading prices, ICCO is priced at $0.00, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas HLTT's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, ICCO and HLTT have similar daily volatility (0.00).
ICCO vs CGNSF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, CGNSF has a market cap of 9K. Regarding current trading prices, ICCO is priced at $0.00, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas CGNSF's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, ICCO and CGNSF have similar daily volatility (0.00).
ICCO vs MOSTQ Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, MOSTQ has a market cap of 8.5K. Regarding current trading prices, ICCO is priced at $0.00, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas MOSTQ's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, ICCO and MOSTQ have similar daily volatility (0.00).
ICCO vs ACNV Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, ACNV has a market cap of 8.1K. Regarding current trading prices, ICCO is priced at $0.00, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas ACNV's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to ACNV's ROE of +0.00%. Regarding short-term risk, ICCO and ACNV have similar daily volatility (0.00).
ICCO vs AHGIF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, AHGIF has a market cap of 7.8K. Regarding current trading prices, ICCO is priced at $0.00, while AHGIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas AHGIF's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, ICCO and AHGIF have similar daily volatility (0.00).
ICCO vs NMXS Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, NMXS has a market cap of 3.8K. Regarding current trading prices, ICCO is priced at $0.00, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas NMXS's P/E ratio is -0.01. In terms of profitability, ICCO's ROE is +0.17%, compared to NMXS's ROE of +1.59%. Regarding short-term risk, ICCO and NMXS have similar daily volatility (0.00).
ICCO vs BBLNF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, BBLNF has a market cap of 2.6K. Regarding current trading prices, ICCO is priced at $0.00, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas BBLNF's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, ICCO and BBLNF have similar daily volatility (0.00).
ICCO vs PCYS Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, PCYS has a market cap of 1.1K. Regarding current trading prices, ICCO is priced at $0.00, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas PCYS's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to PCYS's ROE of -2.71%. Regarding short-term risk, ICCO and PCYS have similar daily volatility (0.00).
ICCO vs OLMM Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, OLMM has a market cap of 1K. Regarding current trading prices, ICCO is priced at $0.00, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas OLMM's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to OLMM's ROE of +0.00%. Regarding short-term risk, ICCO and OLMM have similar daily volatility (0.00).
ICCO vs ETAOF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, ETAOF has a market cap of 512. Regarding current trading prices, ICCO is priced at $0.00, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas ETAOF's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, ICCO and ETAOF have similar daily volatility (0.00).
ICCO vs LGBI Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, LGBI has a market cap of 50. Regarding current trading prices, ICCO is priced at $0.00, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas LGBI's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, ICCO and LGBI have similar daily volatility (0.00).
ICCO vs APYI Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, APYI has a market cap of 34. Regarding current trading prices, ICCO is priced at $0.00, while APYI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas APYI's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to APYI's ROE of -0.60%. Regarding short-term risk, ICCO and APYI have similar daily volatility (0.00).
ICCO vs WTEQF Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, WTEQF has a market cap of 0. Regarding current trading prices, ICCO is priced at $0.00, while WTEQF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas WTEQF's P/E ratio is 1.78. In terms of profitability, ICCO's ROE is +0.17%, compared to WTEQF's ROE of N/A. Regarding short-term risk, ICCO and WTEQF have similar daily volatility (0.00).
ICCO vs VMCS Comparison
ICCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCO stands at 71.7K. In comparison, VMCS has a market cap of 0. Regarding current trading prices, ICCO is priced at $0.00, while VMCS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCO currently has a P/E ratio of -0.40, whereas VMCS's P/E ratio is N/A. In terms of profitability, ICCO's ROE is +0.17%, compared to VMCS's ROE of +3.10%. Regarding short-term risk, ICCO is less volatile compared to VMCS. This indicates potentially lower risk in terms of short-term price fluctuations for ICCO.